Scinovex
article Open Access

Clinico-epidemiological study of central nervous system tumors at clinical oncology department Tanta University Hospitals

International journal of oncology research. · 2024 · Vol. 4(1) · pp. 44–54

Abstract

Background: The most common malignant tumor among central nervous system (CNS) tumors is glioblastoma which has the highest mortality rate. On the other hand, meningioma is known as the most common benign tumor. This work aimed to describe the clinico-epidemiological and pathological pattern of all CNS tumors and to evaluate treatment output (Survival details). Methods: This retrospective study was carried out on 340 patients with CNS tumors. The treatment options depend on several factors, including the type and location of the tumor, how far it has grown or spread and a person's age and overall health [Surgery (craniotomy), radiotherapy, chemoradiotherapy and chemotherapy. Results: The estimated median overall survival of CNS tumors patients was 36 months, also 5-year OS was reported in 48.5% of these patients. Age, pathology and grade that affect progression free survival of CNS tumors which were significantly different (p

Glioma Diagnosis and TreatmentMedicineClinical OncologyEpidemiologyInternal medicineOncologyPathologyCancer
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
19%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.